Research
High genomic diversity of dengue virus strains in Latin America and Asia-Pacific: insights from a phase 2 mosnodenvir clinical trial
Nature ·
The Brief
- A study reports high genomic diversity among dengue virus strains from Latin America and Asia-Pacific.
- The analysis draws on samples from a phase 2 clinical trial of the antiviral mosnodenvir.
- The source feed lists the article under Biological sciences with publication dated 2026-11-11 and provides no summary.
Why it matters
Genomic diversity among dengue strains bears on how well antiviral candidates such as mosnodenvir may work across regions, though the source gives no detail on specific findings.
Who’s affected
- dengue researchers and clinicians
- public health officials in Latin America and Asia-Pacific
- #dengue
- #virology
- #genomics
- #antivirals
- #clinical trials